CHRONIC ADMINISTRATION OF FLUMAZENIL INCREASES LIFE-SPAN AND PROTECTS RATS FROM AGE-RELATED LOSS OF COGNITIVE FUNCTIONS - A BENZODIAZEPINE/GABAERGIC HYPOTHESIS OF BRAIN AGING

被引:28
作者
MARCZYNSKI, TJ
ARTWOHL, J
MARCZYNSKA, B
机构
[1] UNIV ILLINOIS, COLL MED, BIOL RESOURCES LABS, CHICAGO, IL 60612 USA
[2] UNIV ILLINOIS, COLL MED, DEPT MICROBIOL & IMMUNOL, CHICAGO, IL 60612 USA
关键词
FLUMAZENIL; AGING; RATS; RADIAL MAZE; T MAZE; WORKING MEMORY; REFERENCE MEMORY;
D O I
10.1016/0197-4580(94)90146-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Under barrier condition and with ad lib access to food and water, 20 Fischer-344 rats were chronically treated for 10 months with the benzodiazepine (BDZ) antagonist, flumazenil (FL; 4 mg/kg/day in drinking water acidified to pH = 3.0), beginning at the age of 13 months, while the group of 20 control age-matched rats received plain acidified water. The life span of the first 8 deceased rats treated with FL was significantly longer than that of the first 8 deceased rats in the age-matched control group. In tests for spontaneous ambulation and exploratory behavior in the Holeboard apparatus, conducted during the 3rd and the 8th month of treatment, the FL group, relative to controls, had significantly higher scores for the ambulation and exploratory behavior. In tests for unrewarded spontaneous alternation in the T maze, conducted at days 7, 39, 42, and 47 through 54 after drug withdrawal, i.e., at the age of 24-25 months, the FL-exposed group, compared to age-matched controls, showed a significantly higher percent of alternating choices, a behavior that was statistically comparable to that of the ''young'' 6-month-old controls. In the Radial Maze tests conducted 2 months after drug withdrawal, the FL group made significantly less ''working memory'' errors and ''reference memory'' errors, relative to the age-matched 25-month-old control group, a performance that was comparable to that of the young 7-month-old control group. In conclusion, chronic FL significantly protected rats from age-related lass of cognitive functions. It is postulated that the age-related alterations in brain function may be attributable to the negative metabolic/trophic influences of the ''endogenous'' benzodiazepine (BDZ) ligands and/or those ingested with food. A BDZ/GABAergic hypothesis of brain aging has been formulated which assumes that age-related and abnormally strong BDZ/GABAergic influences promote neurodegeneration by suppressing trophic functions of the aminergic and peptidergic neurons through opening of chloride channels in soma membrane and axon terminals, causing excessive hyperpolarizing and depolarizing inhibition, respectively. The review of human clinical and animal data indicates that FL has nootropic actions by enhancing vigilance cognitive and habituation processes.
引用
收藏
页码:69 / 84
页数:16
相关论文
共 135 条
[1]   FUNCTIONAL INTEGRITY OF BENZODIAZEPINE RECEPTORS OF THE GENICULOSTRIATE VISUAL PATHWAYS IN CREUTZFELDT-JAKOB DISEASE - A PHARMACOLOGICAL EVOKED-POTENTIAL STUDY [J].
AGUGLIA, U ;
OLIVERI, RL ;
GAMBARDELLA, A ;
QUATTRONE, A .
JOURNAL OF NEUROLOGY, 1993, 240 (01) :25-27
[2]  
AMSTEN AFT, 1985, ANN NY ACAD SCI, V444, P218
[3]   EFFECTS OF SCOPOLAMINE, D-AMPHETAMINE AND OTHER DRUGS AFFECTING CATECHOLAMINES ON SPONTANEOUS ALTERNATION AND LOCOMOTOR ACTIVITY IN MICE [J].
ANISMAN, H ;
KOKKINIDIS, L .
PSYCHOPHARMACOLOGIA, 1975, 45 (01) :55-63
[4]   INTERCHANGEABILITY OF STRESS AND AMPHETAMINE IN SENSITIZATION [J].
ANTELMAN, SM ;
EICHLER, AJ ;
BLACK, CA ;
KOCAN, D .
SCIENCE, 1980, 207 (4428) :329-331
[5]   ONE STRESSFUL EVENT BLOCKS MULTIPLE ACTIONS OF DIAZEPAM FOR UP TO AT LEAST A MONTH [J].
ANTELMAN, SM ;
KNOPF, S ;
KOCAN, D ;
EDWARDS, DJ ;
RITCHIE, JC ;
NEMEROFF, CB .
BRAIN RESEARCH, 1988, 445 (02) :380-385
[6]  
AOYAGI T, 1990, CHEM PHARM BULL, V38, P1748
[7]   SITE-SPECIFIC ENHANCEMENT AND SUPPRESSION OF DESYNCHRONIZED SLEEP SIGNS FOLLOWING CHOLINERGIC STIMULATION OF 3 BRAIN-STEM REGIONS [J].
BAGHDOYAN, HA ;
RODRIGOANGULO, ML ;
MCCARLEY, RW ;
HOBSON, JA .
BRAIN RESEARCH, 1984, 306 (1-2) :39-52
[8]  
BASILE AS, 1991, PHARMACOL REV, V43, P27
[9]   DO DEFECTS IN MITOCHONDRIAL ENERGY-METABOLISM UNDERLIE THE PATHOLOGY OF NEURODEGENERATIVE DISEASES [J].
BEAL, MF ;
HYMAN, BT ;
KOROSHETZ, W .
TRENDS IN NEUROSCIENCES, 1993, 16 (04) :125-131
[10]   ALZHEIMERS-DISEASE - A METABOLIC SYSTEMS DEGENERATION [J].
BLASS, JP ;
ZEMCOV, A .
NEUROCHEMICAL PATHOLOGY, 1984, 2 (02) :103-114